{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:44:35Z","timestamp":1761518675993,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1023\/a:1013034311284","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T20:49:56Z","timestamp":1040676596000},"page":"163-169","source":"Crossref","is-referenced-by-count":13,"title":["Phase I\/II study of gemcitabine in association with vinorelbine for metastatic breast cancer"],"prefix":"10.1007","volume":"70","author":[{"given":"G.","family":"Mariani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zucchinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Demicheli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valagussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"380714_CR1","first-page":"1602","volume-title":"Cancer Principles and Practice of Oncology","author":"JR Harris","year":"1997","unstructured":"Harris JR, Morrow M, Norton L: Cancer of the breast. Management of metastatic disease. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer Principles and Practice of Oncology. Lippincott, Philadelphia, 1997, pp 1602-1606"},{"issue":"suppl4","key":"380714_CR2","first-page":"9","volume":"16","author":"A Fellous","year":"1989","unstructured":"Fellous A, Ohayon R, Vacassin T, Binet S, Lataste H, Krikorian A, Couzinier JP, Meininger V: Biochemical effects of Navelbine on tubulin and associated proteins. Semin Oncol 16(suppl 4): 9-14, 1989","journal-title":"Semin Oncol"},{"issue":"suppl5","key":"380714_CR3","first-page":"22","volume":"22","author":"P Fumoleau","year":"1995","unstructured":"Fumoleau P, Delozier T, Extra JM, Canobbio L, Delgado FM, Hurteloup P, Hortobagyi GN, Abeloff MD: Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. Semin Oncol 22(suppl 5): 22-29, 1995","journal-title":"Semin Oncol"},{"key":"380714_CR4","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1021\/jo00246a002","volume":"53","author":"LW Hertel","year":"1988","unstructured":"Hertel LW, Kroin JS, Misner JW, Tustin JM: Synthesis of 2-deoxy-2',2'-difluoro-D-ribose and 2-deoxy-2',2'-difluoro-Dribofuranosyl nucleosides. J Org Chem 53: 2406-2409, 1988","journal-title":"J Org Chem"},{"key":"380714_CR5","first-page":"4417","volume":"50","author":"LW Hertel","year":"1990","unstructured":"Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, Grindey GB: Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). Cancer Res 50: 4417-4422, 1990","journal-title":"Cancer Res"},{"key":"380714_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004320050210","volume":"124","author":"D L\u00fcftner","year":"1998","unstructured":"L\u00fcftner D, Flath B, Akrivakis C, Grunewald R, Mergenthaler HG, Possinger K: Gemcitabine for palliative treatment in metastatic breast cancer. J Cancer Res Clin Oncol 124: 527-531, 1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"380714_CR7","first-page":"117","volume":"15","author":"M Blackstein","year":"1996","unstructured":"Blackstein M, Vogel CL, Ambinder R, Cowan J, Pearce P, Iglesias J, Dorr FA: Phase II study of gemcitabine in patients with metastatic breast cancer. Proc. ASCO (American Society of Clinical Oncology) 15: 117 (abstract 135), 1996","journal-title":"Proc. ASCO (American Society of Clinical Oncology)"},{"issue":"suppl6","key":"380714_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00001813-199512006-00009","volume":"6","author":"K Possinger","year":"1995","unstructured":"Possinger K: Gemcitabine in advanced breast cancer. Anticancer Drugs 6(suppl 6): 55-60, 1995","journal-title":"Anticancer Drugs"},{"key":"380714_CR9","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1995.13.11.2731","volume":"13","author":"J Carmichael","year":"1995","unstructured":"Carmichael J, Possinger K, Phillip P, Beykirch M, Kerr H, Walling J, Harris AL: Advanced breast cancer: a phase II trial with gemcitabine. J Clin Oncol 13: 2731-2736, 1995","journal-title":"J Clin Oncol"},{"key":"380714_CR10","first-page":"236","volume":"41","author":"M Spielmann","year":"1996","unstructured":"Spielmann M, Pouillart P, Espie M, Llombart-Cussac A, Namer M, Kalla S, Ferrero JM, Cuvier C, Fumoleau P, Ponzio A, Kayitalire L: Activity of gemcitabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containing regimens. Breast Cancer Res Treat 41: 236 (abstract 143), 1996","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl12","key":"380714_CR11","first-page":"123","volume":"22","author":"GW Sledge Jr","year":"1995","unstructured":"Sledge GW Jr: Doxorubicin\/paclitaxel combination chemotherapy for metastatic breast cancer: The Eastern Cooperative Oncology Group experience. Semin Oncol 22(suppl 12): 123-125, 1995","journal-title":"Semin Oncol"},{"key":"380714_CR12","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1200\/JCO.1995.13.11.2688","volume":"13","author":"L Gianni","year":"1995","unstructured":"Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni A, Martini C: Paclitaxel by three-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13: 2688-2699, 1995","journal-title":"J Clin Oncol"},{"key":"380714_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01806156","volume":"39","author":"M Terenziani","year":"1996","unstructured":"Terenziani M, Demicheli R, Brambilla C, Ferrari L, Moliterni A, Zambetti M, Caraceni A, Martini C, Bonadonna G: Vinorelbine: an active non cross-resistant drug in advanced breast cancer. Results from a phase II study. Breast Cancer Res Treat 39: 285-291, 1996","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"380714_CR14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0959-8049(98)00235-4","volume":"34","author":"G Krajnik","year":"1998","unstructured":"Krajnik G, Wein R, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zochbauer-Muller S, Huber H, Pirker R: Vinorelbine\/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial. Euro J Cancer, 34,(12): 1977-1980, 1998","journal-title":"Euro J Cancer"},{"key":"380714_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-5002(99)00092-6","volume":"27","author":"C Camps-Herrero","year":"2000","unstructured":"Camps-Herrero C, Martinez NE, Berrocal Jaime A: Secondline treatment with gemcitabine and vinorelbine in non-smallcell lung cancer (NSCLC) cisplatin failures: a pilot study. Lung Cancer 27: 47-53, 2000","journal-title":"Lung Cancer"},{"key":"380714_CR16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1023\/A:1008370704612","volume":"11","author":"G Krajnik","year":"2000","unstructured":"Krajnik G, Mohn-Staudner A, Thaler J, Griel R, Schmeikal S, Marhold F, Deutsch J, Preiss P, Malayeri R, Schafer-Prokop C, Wein W, Huber H, Pirker R: Vinorelbine-gemcitabine in advanced non-small cell lung cancer (NSCLC): an AASLC phase II trial. Ann Oncol 11: 993-998, 2000","journal-title":"Ann Oncol"},{"issue":"6","key":"380714_CR17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1353::AID-CNCR11>3.0.CO;2-A","volume":"88","author":"JD Hainsworth","year":"2000","unstructured":"Hainsworth JD, Burris HA, Litchy S, Erland JB, Hon JK, Brierre JE, Greco FA: Gemcitabine and vinorelbine in the second-line treatment of non-small cell lung carcinoma patients. AMinnie Pearl Cancer Research Network phase II trial. Cancer 15, 88(6): 1353-1358, 2000","journal-title":"Cancer 15"},{"key":"380714_CR18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1023\/A:1008361711049","volume":"11","author":"C Nicolaides","year":"2000","unstructured":"Nicolaides C, Dimopoulos MA, Samantas E, Bafaloukos D, Kalofonos C, Fountzilas G, Razi E, Kosmidis P, Pavlidis N: Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progression after first-line taxane-based chemotherapy. A phase II study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 11: 873-875, 2000","journal-title":"Ann Oncol"},{"key":"380714_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1008348704373","volume":"11","author":"R Valenza","year":"2000","unstructured":"Valenza R, Leonardi V, Gebbia V, Agostara B: Gemcitabine and vinorelbine in pretrated advanced breast cancer: a pilot study. Ann Oncol 11: 495-496, 2000","journal-title":"Ann Oncol"},{"issue":"suppl5","key":"380714_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1008484206680","volume":"9","author":"P Borchmann","year":"1998","unstructured":"Borchmann P, Schnell R, Diehl V, Engert A: New drugs in the treatment of Hodgkin's disease. Ann Oncol 9(suppl 5): 103-108, 1998","journal-title":"Ann Oncol"},{"key":"380714_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1008352227275","volume":"11","author":"JP Delord","year":"2000","unstructured":"Delord JP, Raymond E, Chaouche M, Ruffie P, Ducreux M, Faivre S, Boige V, Le Chevalier T, Rixe O, Baudin E, Pautier P, Rodier JM, Chouaki N, Escudier B, Kayitalire L, Armand JP: A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies. Ann Oncol 11: 73-79, 2000","journal-title":"Ann Oncol"},{"key":"380714_CR22","first-page":"362a","volume":"19","author":"N Caristi","year":"2000","unstructured":"Caristi N, Maisano R, Spadaro P, Toscano G, Scimone A, Pergolizzi A, Gnani A, Cascinu S: Gemcitabine and vinorelbine combination in patients older than 70 years or unresponsive to a cisplatin chemotherapy in advanced bladder cancer. Proc ASCO 19: 362a (abstract 1429), 2000","journal-title":"Proc ASCO"},{"issue":"3","key":"380714_CR23","first-page":"557","volume":"88","author":"R Lilenbaum","year":"2000","unstructured":"Lilenbaum R, Cano R, Schwartz M, Siegel L, Lutzky J, Lewis M, Krill E, Barreras L, Davila E: Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma. A phase II study Cancer 88(3): 557-562, 2000","journal-title":"A phase II study Cancer"},{"issue":"2","key":"380714_CR24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2000.18.2.405","volume":"18","author":"V Lorusso","year":"2000","unstructured":"Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S, De Lena M: Phase I\/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small cell lung cancer. J Clin Oncol 18(2): 405-411, 2000","journal-title":"J Clin Oncol"},{"key":"380714_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1005769604001","volume":"44","author":"M Zambetti","year":"1997","unstructured":"Zambetti M, Demicheli R, De Candis D, Antonelli G, Giacobone A, Terenziani M, Laffranchi A, Garbagnati F, Biasi S, Bonadonna G: Five-days infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients. Breast Cancer Res Treat 44: 255-260, 1997","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"380714_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006445713773","volume":"62","author":"M Zambetti","year":"2000","unstructured":"Zambetti M, Mariani G, Demicheli R, Verderio P, Potepan P, Garbagnati F: Five-days infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxel. Breast Cancer Res Treat 62(2): 135-139, 2000","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1013034311284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1013034311284\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1013034311284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1013034311284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:22:29Z","timestamp":1750479749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1013034311284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["380714"],"URL":"https:\/\/doi.org\/10.1023\/a:1013034311284","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}